Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
Powers of the likelihood ratio test and the correlation test using empirical bayes estimates for various shrinkages in population pharmacokinetics.
A mechanism-based model for the population pharmacokinetics of free and bound aflibercept in healthy subjects.
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics
Methods and software tools for design evaluation for population pharmacokinetics-pharmacodynamics studies.: Softwares for design evaluation in population PKPD
Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.
Population pharmacokinetics of levobupivacaine during a transversus abdominis plane block in children
Pharmacokinetics of intramuscular alfaxalone and its echocardiographic, cardiopulmonary and sedative effects in healthy dogs.
Influence of alpha-1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in HIV-infected patients included in the ANRS 107 trial.: alpha 1 glycoprotein acid polymorphism and atazanavir pharmacokinetics
Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles.